Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_assertion type Assertion NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_head.
- NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_assertion description "[In contrast, it was rarely detected in adenomyosis, leiomyoma and normal ovary tissues, showing its higher specificity (97%) to CA125 (65%) in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_provenance.
- NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_assertion evidence source_evidence_literature NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_provenance.
- NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_assertion SIO_000772 21399663 NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_provenance.
- NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_assertion wasDerivedFrom befree-20140225 NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_provenance.
- NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_assertion wasGeneratedBy ECO_0000203 NP207165.RAhyt77dgbxTfFpJ-3YKd68F_sCMO242Sa59BjOP5iDUU130_provenance.